OBESITY AND IN-HOSPITAL OUTCOMES AMONG PATIENTS WITH SEVERE COVID-19 IN VIET NAM

Trieu Ly Vo, Tuan Long Nguyen, Minh Nhut Vuong, Hoang Phi Nguyen, Thi Hieu Vu
{"title":"OBESITY AND IN-HOSPITAL OUTCOMES AMONG PATIENTS WITH SEVERE COVID-19 IN VIET NAM","authors":"Trieu Ly Vo, Tuan Long Nguyen, Minh Nhut Vuong, Hoang Phi Nguyen, Thi Hieu Vu","doi":"10.51298/vmj.v538i1.9553","DOIUrl":null,"url":null,"abstract":"Introduction: COVID-19 (Coronavirus disease 2019) is a global pandemic. Overweight and obesity are risk factors related to mortality as well as disease severity. Overweight and obesity are also increasing in Vietnam. Data related to the characteristics of COVID-19 in this vulnerable population was limited in Vietnam. The study was conducted (1) to describe the outcomes of overweight and obese COVID-19 patients, and (2) to investigate factors associated with the outcomes of overweight and obese COVID-19 patients. Methods: A cross-sectional description was conducted at the Hospital for Tropical Diseases from July 2021 to December 2021. Patients who were (1) ≥ 18 years old (2) diagnosed with COVID-19 with a positive RT-PCR SARS-CoV-2 result and (3) had BMI ≥ 23 kg/m2. Female pregnant women or ascites were excluded from this study. To determine factors associated with mortality and ICU admission, chi-square and Fisher's Exact were used. Variables with p < 0.05 were included in the logistic regression model to investigate independent risk factors. Cases directly admitted to the ICU were excluded when analyzing risk factors for ICU admission. Results: 173 patients were recruited (70 patients (40.46%) were overweight, 74 patients (42.77%) were obesity class I and 29 patients (16.76%) were obesity class II). The overall mortality rate was 28.9%. The ICU admission rate was 46.2% with a median ICU stay of 9 (6 – 15.25) days. The rate of respiratory support was 83.8%, of which 31.8% of patients required invasive mechanical ventilation and the median duration of respiratory support was 12 (6.5 – 16.5) days. Independently factors associated with ICU admission were diabetes (OR = 2.92 (1.27 – 6.67)) and a severe or critical condition at admission (OR = 8.82 (2.51 – 31.08). Independently factors associated with death were vaccination (OR = 0.23 (0.08 – 0.63)), a severe or critical at admission (OR = 15.74 (3.46 – 71.55)) and remdesivir usage (OR = 0.78 (0.16 – 0.87)). Recommendation: Vaccination against COVID-19 has been shown to be effective in the obese and overweight population.","PeriodicalId":22277,"journal":{"name":"Tạp chí Y học Việt Nam","volume":" 450","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tạp chí Y học Việt Nam","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51298/vmj.v538i1.9553","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: COVID-19 (Coronavirus disease 2019) is a global pandemic. Overweight and obesity are risk factors related to mortality as well as disease severity. Overweight and obesity are also increasing in Vietnam. Data related to the characteristics of COVID-19 in this vulnerable population was limited in Vietnam. The study was conducted (1) to describe the outcomes of overweight and obese COVID-19 patients, and (2) to investigate factors associated with the outcomes of overweight and obese COVID-19 patients. Methods: A cross-sectional description was conducted at the Hospital for Tropical Diseases from July 2021 to December 2021. Patients who were (1) ≥ 18 years old (2) diagnosed with COVID-19 with a positive RT-PCR SARS-CoV-2 result and (3) had BMI ≥ 23 kg/m2. Female pregnant women or ascites were excluded from this study. To determine factors associated with mortality and ICU admission, chi-square and Fisher's Exact were used. Variables with p < 0.05 were included in the logistic regression model to investigate independent risk factors. Cases directly admitted to the ICU were excluded when analyzing risk factors for ICU admission. Results: 173 patients were recruited (70 patients (40.46%) were overweight, 74 patients (42.77%) were obesity class I and 29 patients (16.76%) were obesity class II). The overall mortality rate was 28.9%. The ICU admission rate was 46.2% with a median ICU stay of 9 (6 – 15.25) days. The rate of respiratory support was 83.8%, of which 31.8% of patients required invasive mechanical ventilation and the median duration of respiratory support was 12 (6.5 – 16.5) days. Independently factors associated with ICU admission were diabetes (OR = 2.92 (1.27 – 6.67)) and a severe or critical condition at admission (OR = 8.82 (2.51 – 31.08). Independently factors associated with death were vaccination (OR = 0.23 (0.08 – 0.63)), a severe or critical at admission (OR = 15.74 (3.46 – 71.55)) and remdesivir usage (OR = 0.78 (0.16 – 0.87)). Recommendation: Vaccination against COVID-19 has been shown to be effective in the obese and overweight population.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
越南严重颅内压增高-19 患者的肥胖与住院治疗结果
导言COVID-19(冠状病毒病 2019)是一种全球性流行病。超重和肥胖是与死亡率和疾病严重程度相关的风险因素。超重和肥胖在越南也呈上升趋势。在越南,与这一易感人群中 COVID-19 特征相关的数据非常有限。本研究的目的是:(1) 描述超重和肥胖 COVID-19 患者的预后;(2) 调查与超重和肥胖 COVID-19 患者预后相关的因素。研究方法2021 年 7 月至 2021 年 12 月在热带病医院进行了横断面描述。患者年龄(1)≥18岁(2)确诊为COVID-19且RT-PCR SARS-CoV-2结果呈阳性(3)体重指数(BMI)≥23 kg/m2。本研究排除了女性孕妇或腹水患者。为确定与死亡率和入住重症监护室相关的因素,采用了卡方检验和费雪精确检验。P<0.05的变量被纳入逻辑回归模型,以研究独立的风险因素。在分析入住重症监护室的风险因素时,不包括直接入住重症监护室的病例。结果共招募了 173 名患者(70 名患者(40.46%)超重,74 名患者(42.77%)肥胖 I 级,29 名患者(16.76%)肥胖 II 级)。总死亡率为 28.9%。重症监护室入院率为 46.2%,重症监护室住院时间中位数为 9(6 - 15.25)天。呼吸支持率为83.8%,其中31.8%的患者需要有创机械通气,呼吸支持的中位持续时间为12(6.5 - 16.5)天。糖尿病(OR = 2.92 (1.27 - 6.67))和入院时病情严重或危重(OR = 8.82 (2.51 - 31.08))是入住重症监护室的独立相关因素。与死亡无关的因素包括疫苗接种(OR = 0.23 (0.08 - 0.63))、入院时病情严重或危重(OR = 15.74 (3.46 - 71.55))和使用雷米地韦(OR = 0.78 (0.16 - 0.87))。建议:接种 COVID-19 疫苗已被证明对肥胖和超重人群有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
MỘT SỐ YẾU TỐ NGUY CƠ CỦA ĐÁI THÁO ĐƯỜNG THAI KỲ: NGHIÊN CỨU BỆNH CHỨNG TRẦM CẢM VÀ MỘT SỐ YẾU TỐ LIÊN QUAN CỦA HỌC SINH TRUNG HỌC PHỔ THÔNG TẠI THÀNH PHỐ VĨNH LONG, TỈNH VĨNH LONG NĂM 2023 KHẢO SÁT NỒNG ĐỘ HEPCIDIN HUYẾT TƯƠNG Ở BỆNH NHÂN BỆNH THẬN MẠN TÍNH GIAI ĐOẠN CUỐI QUAN ĐIỂM VỀ SỨC KHỎE SINH SẢN VÀ ĐỀ XUẤT CAN THIỆP CHO NỮ SINH TRUNG HỌC CƠ SỞ TẠI THÀNH PHỐ CẦN THƠ HIỆU QUẢ VÀ AN TOÀN CỦA KỸ THUẬT KHOAN CẮT HẸP ĐỘNG MẠCH VÀNH VÔI HÓA NẶNG TẠI BỆNH VIỆN ĐA KHOA TỈNH KIÊN GIANG
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1